Xeber.world
BeOne Therapeutics has received FDA approval for its breakthrough cell therapy targeting lymphoma, marking a significant milestone in biotech innovati...
The FDA’s rejection of RP1, an experimental melanoma treatment, highlights the limitations of the 2018 Right to Try Act. Despite its promise to grant...
Hims & Hers, a leading telehealth company, reported a sales miss as competition in the digital health space intensifies. The company's financial resul...
Entrada Therapeutics’ next-generation exon-skipping drug for Duchenne muscular dystrophy underperformed in early trials, raising doubts about its comp...
Singapore hospitals now offer a 3D-printed cast that is waterproof, comfortable, and easier to apply than traditional casts. Developed by startup Cast...
Novo Nordisk’s new weight-loss pill, Wegovy, has achieved 1.3 million prescriptions in Q1 2026, prompting the company to raise its full-year guidance....
A researcher with a decade of experience in psychedelic treatments praises President Trump’s executive order on psychedelic medicines as a significant...
A recent court ruling reinstated in-person dispensing requirements for mifepristone, challenging the FDA's regulatory authority. The Supreme Court tem...
The U.S. Supreme Court has temporarily reinstated broad access to the abortion pill mifepristone, allowing distribution via telehealth, mail, and phar...
The U.S. Supreme Court temporarily blocked a lower court ruling that restricted access to the abortion pill mifepristone, including mail distribution....
UCB announces plans to acquire Zymvol Biomarker Research, a leader in antibody treatments for autoimmune diseases. The deal strengthens UCB's pipeline...
Axsome Therapeutics has received FDA approval for its Alzheimer’s agitation drug, marking a significant advancement in neurotherapeutic treatments. Th...
Joe Rogan’s private text to Donald Trump sparked a White House executive order fast-tracking psychedelic therapies. The move, championed by Rogan and...
The Trump administration has directed the FDA to expedite approval of psychedelic therapies, including ibogaine, for PTSD and other mental health diso...
Intellia Therapeutics reported that a single dose of its CRISPR-based gene editing therapy, lonvo-z, dramatically reduced swelling attacks in a Phase...
Intellia Therapeutics announced Monday that a single dose of its CRISPR-based gene editing treatment, lonvo-z, dramatically reduced swelling attacks i...
The FDA has approved an initial feasibility trial for a baseball cap-like device developed by Motif Neurotech. The device, which activates a brain imp...
Health policy experts and legislators are raising concerns over high fees paid by pharmaceutical companies to telehealth providers, potentially violat...
Addyi, the controversial 'little pink pill' for low libido in premenopausal women, expanded its FDA approval in December to include all women under 65...
Roche has presented new trial data for its experimental multiple sclerosis drug fenebrutinib, aiming to secure regulatory approval. While the drug sho...
President Trump and his administration are aggressively courting Joe Rogan, despite the podcast host's vocal criticism of the Iran war. Rogan's influe...
The FDA has approved a 7.2 mg weekly dose of Wegovy, a GLP-1 medication, for weight loss. Clinical trials show this higher dose can lead to 25% more w...
The FDA has granted fast-track approval to Foundayo, a once-daily GLP-1 pill for weight loss developed by Eli Lilly. The medication, designed for adul...
The FDA has cleared the Onclarity HPV Self-Collection Kit from Waters Corporation, a new at-home cervical cancer screening tool. The kit, available wi...
President Trump signed an executive order accelerating research on psychedelic drugs like ibogaine for treating depression and PTSD. Joe Rogan, who ha...